Trial Profile

A phase III study of Interferon-alpha-2a in Oral Warts in HIV-Seropositive Patients

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 21 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha-2a (Primary)
Indications Warts
Focus Registrational; Therapeutic Use
Sponsors Ainos

Most Recent Events

21 Sep 2023 New trial record
18 Sep 2023 According to an Ainos media release, company plans to pursue a pre IND meeting with the U.S. FDA and plans to advance its VELDONA formulation to Phase III clinical trials.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com